The Genetics Generation Advancement Corporation(GGA Corp.)focuses on five major disciplines of precision medicine : maternal-fetal precision medicine, pediatric disease diagnosis, companion diagnostics, non-invasive cancer screening and precision health management.


The First
  • The 1st publicly traded company specializing in genetic diagnosis and scientific informatics in Taiwan with its IPO (4160-TW) in 2012.
  • The 1st to successfully introduce Spinal Muscular Atrophy Carrier Testing (SMA), Maternal Serum Down Syndrome Screening Test (SDS), Pre-implantation Genetic Diagnosis (PGD), UltraPGD, Pre-implantation Genetic Screening (PGS) and Next-Generation Sequencing (NGS)-based PGS into the Taiwan market.
  • The 1st laboratory in Taiwan to be accredited by the College of American Pathologists (CAP) and Taiwan Accreditation Foundation (TAF), as well as granted Affymetrix® Service Provider and Illumina® CSPro certificate.



The More
  • Serving around 50% of newborn babies every year in Taiwan
  • Expanding overseas business successfully by providing genetic testing services in Asia, Europe and the Americas
  • Establishing a Genetic Counseling Team, a first in the industry, to deliver expert genetic support to the clients
  • Building a complete platform of global standard for genetic testing with state-of-the-art laboratory facilities and equipment including next-generation sequencing and single nucleotide polymorphism (SNP) microarray devices


The Better
  • The 1st biotech company in Taiwan with a full-fledged informatics business unit, Molecular Science Center (MSC), whose solutions and services span bioinformatics, life sciences, materials sciences, and enterprise laboratory and quality management.

  • Named Deloitte’s Technology Fast 500 Asia Pacific Companies in 2012 & 2013 for its revenue growth over the 3-year period.